螺[4.5]癸烷-1-酮 | 4728-91-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 螺[4.5]癸烷-1-酮
• 中文别名: 螺[4.5]癸-1-酮
• 英文名称: spiro[4.5]decan-1-one
• 英文别名: Spiro<4.5>decanon-(1)；spiro[4.5]decan-4-one
• CAS: 4728-91-0
• 化学式: C₁₀H₁₆O
• 分子量: 152.236
• InChiKey: FPVZWDQWFCGSFY-UHFFFAOYSA-N

物化性质

• 沸点：
  107-114 °C(Press: 22 Torr)
• 密度：
  0.978 g/cm3(Temp: 25 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2914299000

反应信息

• 作为反应物：
  描述：

  螺[4.5]癸烷-1-酮 在 sodium azide 、 PPA 作用下， 生成 3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one
  参考文献：
  名称：

  Conley; Nowak, Chemistry and industry, 1959, p. 1161

  摘要：

  DOI：
• 作为产物：
  描述：

  环己甲酸甲酯 在 tris(dibenzoylmethano)iron(III) samarium diiodide 、 sodium iodide 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 六甲基磷酰三胺 、 丙酮 为溶剂， 反应 16.25h， 生成 螺[4.5]癸烷-1-酮
  参考文献：
  名称：

  Intramolecular nucleophilic acyl substitution reactions of halo-substituted esters and lactones. New applications of organosamarium reagents

  摘要：

  Intramolecular nucleophilic acyl substitution reactions involving a broad range of halo substituted carboxylic acid derivatives have been accomplished in excellent yield employing samarium(II) iodide as the reductive coupling agent. Although particular substrates cyclized most effectively in THF in the presence of tripiperidinophosphine oxide, carboxylic acid esters, the focus of this report, cyclize equally well without such an additive in the presence of a catalytic quantity of iron(III) complexes. Thus a comprehensive series of halo substituted esters were cyclized in excellent yield to the corresponding 4-, 5-, and 6-membered carbocycles. The reaction is extremely mild and selective as demonstrated by experiments wherein alkyl chlorides, acetals, and olefins remain completely intact under the reaction conditions. In addition to introducing a convenient procedure for preparing stereodefined spirocyclic systems, a new ring expansion sequence has been developed that appears extremely general for the preparation of various ring systems.

  DOI：

  10.1021/jo00077a053

文献信息

• Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors
  申请人：Mjalli M.M. Adnan

  公开号：US20070191385A1

  公开（公告）日：2007-08-16

  The present invention provides imidazole derivatives of Formula (I-IV), methods of their preparation, pharmaceutical compositions comprising the compounds of Formula (I-IV), and their use in treating human or animal disorders. The compounds of the invention inhibit protein tyrosine phosphatase 1B and thus can be useful for the management, treatment, control, or the adjunct treatment of diseases mediated by PTPase activity. Such diseases include Type I diabetes and Type II diabetes.

  本发明提供了式(I-IV)的咪唑衍生物，其制备方法，包含式(I-IV)化合物的药物组合物，以及它们在治疗人类或动物疾病中的应用。该发明的化合物抑制蛋白酪氨酸磷酸酶1B，因此可用于管理、治疗、控制或辅助治疗由PTPase活性介导的疾病。这些疾病包括I型糖尿病和II型糖尿病。
• [EN] 2-AMINOPYRIDINE COMPOUNDS<br/>[FR] COMPOSÉS DE 2-AMINOPYRIDINE
  申请人：MERCK PATENT GMBH

  公开号：WO2014063778A1

  公开（公告）日：2014-05-01

  The invention provides novel substituted 2-aminopyridine compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.

  这项发明提供了根据式(I)提供的新型取代的2-氨基吡啶化合物，其制备和用于治疗癌症、炎症或退行性疾病等增生性疾病。
• Relay‐Heck Cross‐Coupling Between Alkenyl Halides and Unsaturated Alcohols in the Synthesis of Open‐Chain Analogues of Musk Odorant Vulcanolide
  作者：Anthony Lenormand、Lucía Reyes Méndez、Julien Coulomb

  DOI：10.1002/chem.202101080

  日期：2021.6.25

  aldehydes and ketones in moderate to good yields. In contrast, alkenyl triflates were not suitable partners for this reaction. This method allowed the preparation of open-chain analogues of the musk odorant Vulcanolide, several of which retained key olfactory properties of the parent molecule.

  未活化的烯基碘化物和溴化物与一系列不同链长的烯醇进行了前所未有的钯催化中继-赫克交叉偶联，将烯烃和醇连接起来，以中等至良好的产率提供不饱和醛和酮。相比之下，烯基三氟甲磺酸酯不是该反应的合适伙伴。这种方法允许制备麝香气味剂 Vulcanolide 的开链类似物，其中一些保留了母体分子的关键嗅觉特性。
• Novel diazepan derivatives
  申请人：Aebi Johannes

  公开号：US20070249589A1

  公开（公告）日：2007-10-25

  The invention is concerned with novel diazepan derivatives of formula (I) wherein A, X, R 3 , R 4 , R 5 , R 6 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.

  这项发明涉及式（I）的新型二氮杂环己烷衍生物，其中A、X、R3、R4、R5、R6、R8、R9、R10、R11、R12、R13、m和n的定义如描述和索赔中所述，以及其生理上可接受的盐。这些化合物是CCR-2受体、CCR-5受体和/或CCR-3受体的拮抗剂，可用作药物。
• [EN] SUBSTITUTED PHENYL CYCLOALKYL PYRROLIDINE (PIPERIDINE) SPIROLACTAMS AND AMIDES, PREPARATION AND THERAPEUTIC USE THEREOF<br/>[FR] SPIROLACTAMES ET AMIDES DE PHÉNYLCYCLOALKYLPYRROLIDINE (PIPÉRIDINE) SUBSTITUÉS, LEUR PRÉPARATION ET LEUR UTILISATION THÉRAPEUTIQUE
  申请人：SANOFI SA

  公开号：WO2011143150A1

  公开（公告）日：2011-11-17

  The present invention discloses and claims respectively a series of substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides of formula (I) (Ia) and formula (Ib) as described herein. More specifically, the compounds of this invention are modulators of H3 receptors and are, therefore, useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases modulated by H3 receptors including diseases associated with the central nervous system. Additionally, this invention also discloses methods of preparation of substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides of formula (Ia) and (Ib), and intermediates therefor.

  本发明分别公开和声明了一系列取代苯基环烷基吡咯烷（哌啶）螺内酰胺和酰胺的化合物，其化学式如下（I）（Ia）和（Ib）。更具体地，本发明的化合物是H3受体调节剂，因此在治疗和/或预防包括与中枢神经系统相关的多种疾病在内的由H3受体调节的疾病中特别有用。此外，本发明还公开了取代苯基环烷基吡咯烷（哌啶）螺内酰胺和酰胺的制备方法，以及其中间体。